Meta-regression analysis of follow-up time affecting heterogeneity (tirofiban versus DAPT)
| Variable | Coefficient (95% CI) | Standard Error | T | P Value |
|---|---|---|---|---|
| Thromboembolic complications | 0.005 (−0.005–0.014) | 0.004 | 1.160 | .285 |
| Hemorrhagic complications | 0.002 (−0.078–0.116) | 0.004 | 0.460 | .656 |
| Perioperative mortality related to antiplatelet medication | 0.007 (−0.03–0.017) | 1.710 | 1.710 | .131 |
| Good clinical outcomes | –0.006 (−0.017–0.006) | 0.005 | −1.210 | .281 |